PA antes up for biodefense center vax facility; BMS taps Johnson Controls for facility management;

> Pennsylvania is making a $30-million contribution to the construction of an $830-million vaccine-producing biodefense center, to be built in Allegheny County. Article

> Bristol-Myers Squibb has selected Johnson Controls as its outsourcing partner to manage facilities in North America. Article

> Deacom, maker of enterprise resource planning software for the pharma and other vertical industries, has launched a social networking user group available via LinkedIn. Release

> Pharming Group and Sanofi Chimie have signed an agreement increasing production capacity for the drug substance Ruconest. Release

> The European Union is steering doctors toward prescribing Shire's Fabry disease drug Replagal rather than Genzyme's Fabrazyme due to the latter's ongoing manufacturing and supply challenges. Article

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.